Score Overview
Adicet Bio Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 17M to $ 0.00 and net income went from -$ 36M to -$ 116M. Revenue increased in 1 of those 5 years; net income in 3.
Adicet Bio Inc currently holds a 5-year HDB Score of 3.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 8.26 | — |
1 Year2025-08-12 | $ 10.22 | -19.21% |
5 Years2021-08-12 | $ 114.08 | -92.76% |
All Time2018-01-26 | $ 1.89K | -99.56% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-01-26 |
|---|---|---|---|---|
| Price | $ 8.26 | $ 10.22 | $ 114.08 | $ 1.89K |
| Return | — | -19.21% | -92.76% | -99.56% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 98M | $ 33M |
| 2025 | $ 0.00 | -$ 116M | $ 158M |
| 2024 | $ 0.00 | -$ 117M | $ 176M |
| 2023 | $ 0.00 | -$ 142M | $ 159M |
| 2022 | $ 24M | -$ 69M | $ 257M |
| 2021 | $ 9M | -$ 61M | $ 277M |
| 2020 | $ 17M | -$ 36M | $ 94M |
| 2019 | $ 995K | -$ 28M | $ 62M |
| IPO2018 | $ 8M | -$ 9M | $ 108M |
Explore beyond ACET
You're looking at Adicet Bio Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.